Provided by Tiger Trade Technology Pte. Ltd.

C4 Therapeutics, Inc.

2.91
+0.12504.50%
Volume:1.27M
Turnover:3.67M
Market Cap:283.46M
PE:-1.74
High:2.97
Open:2.78
Low:2.78
Close:2.78
52wk High:3.65
52wk Low:1.09
Shares:97.58M
Float Shares:72.05M
Volume Ratio:1.49
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6711
EPS(LYR):-1.5181
ROE:-59.98%
ROA:-23.20%
PB:1.84
PE(LYR):-1.91

Loading ...

Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Correspondence

Form CORRESP - Correspondence
Nov 08, 2024

Correspondence

Form CORRESP - Correspondence
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 11, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]